Point of Care Ultrasound (POCUS) Market Size & Share 2026-2035

Point of Care Ultrasound (POCUS) Market Size

The global point of care ultrasound market was valued at USD 4.2 billion in 2025 and is projected to grow from USD 4.5 billion in 2026 to USD 9 billion by 2035, expanding at a CAGR of 8%, according to the latest report published by Global Market Insights Inc. The steady growth of the market is driven by the increasing prevalence of chronic diseases, advancements in point-of-care ultrasound (POCUS) technology, and a growing geriatric population base.

A point-of-care ultrasound (POCUS) refers to the use of portable ultrasound devices at the patient’s bedside or point of care to obtain real-time diagnostic images and guide clinical decisions. Unlike traditional ultrasound performed in radiology departments, POCUS is typically used by the treating clinician during patient care. It enables rapid assessment, procedural guidance, and monitoring without the delays associated with conventional imaging workflows.

The major players in the global market are Canon Medical Systems, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and GE Healthcare. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in the market.

The market grew from USD 3.5 billion in 2022 to USD 4 billion in 2024, registering a historical growth rate of 6.1%. The rising prevalence of chronic diseases, such as cardiovascular diseases, cancer, kidney disorders, and other chronic conditions, is a major driver for the point-of-care ultrasound (POCUS) market. For example, according to the World Health Organization (WHO), noncommunicable diseases (NCDs) are responsible for 41 million deaths annually, accounting for 74% of global mortality. Each year, 17 million people die from NCDs before reaching the age of 70, with 86% of these premature deaths occurring in low- and middle-income countries. The rising burden of these conditions is increasing the need for rapid, bedside diagnostic tools for early detection, monitoring, and disease management. As a result, healthcare providers are increasingly adopting point-of-care ultrasound (POCUS) due to its ability to enable real-time imaging, improve clinical decision-making, and enhance patient outcomes across a wide range of chronic diseases, thereby driving market growth.

Additionally, the growing geriatric population base is a significant driver for the point-of-care ultrasound (POCUS) market. As global demographics shift toward older age groups, the prevalence of age-related conditions such as cardiovascular diseases, cancer, kidney disorders, and musculoskeletal issues continues to rise, creating greater demand for rapid and accessible diagnostic tools. For instance, according to the WHO, the global population aged 60 years and over is projected to increase from 1 billion in 2020 to 1.4 billion by 2030, eventually doubling to 2.1 billion by 2050. Furthermore, the number of individuals aged 80 years and older is expected to triple from 2020 to 2050, reaching 426 million. Thus, this demographic shift underscores the growing need for portable, real-time imaging solutions like POCUS, which enable timely diagnosis and monitoring of chronic and age-related conditions at the point of care.

Point of Care Ultrasound (POCUS) Market Trends

• Several trends are shaping the market. Continuous technological innovations in POCUS devices are significantly enhancing portability, speed, and ease of use, thereby transforming bedside diagnostics. These advancements enable real-time imaging across diverse clinical settings such as emergency medicine, critical care, and resource-limited environments, while simultaneously improving diagnostic accuracy, functionality, and accessibility.
• The rapid transition from conventional bulky ultrasound systems to lightweight, handheld devices represents a major trend in the market. Modern POCUS devices offer unmatched portability and user convenience, often integrating seamlessly with smartphones or tablets. This enables their use in dynamic environments such as ambulances and remote clinics, ensuring timely and accurate imaging and significantly improving patient care outcomes in critical situations.
• For instance, GE Healthcare’s Vscan Air is a wireless, pocket-sized ultrasound device designed to deliver high-quality, whole-body imaging. It supports early-stage assessments as well as ongoing treatment monitoring, combining portability with advanced diagnostic capabilities across various care settings.
• Advancements in transducer design and signal processing technologies are further driving market growth by significantly improving image resolution in portable devices. Modern POCUS systems now support advanced imaging modalities such as Doppler, elastography, and even 3D/4D imaging, thereby expanding their application scope from basic assessments to comprehensive diagnostic evaluations.

Point of Care Ultrasound (POCUS) Market Analysis

Based on type, the point of care ultrasound market is segmented into diagnostic devices and therapeutic devices. The diagnostic devices segment was valued at USD 2.7 billion in 2025 and held a significant market share of 62.8%.

• The dominance of the diagnostic devices segment is primarily attributed to its critical role in point-of-care imaging, enabling real-time assessments across emergency medicine, critical care, and outpatient settings. These devices allow clinicians to instantly visualize organs, tissues, and vascular structures, supporting rapid clinical decision-making and facilitating timely, life-saving bedside interventions.
• Technological advancements have further strengthened this segment, with modern POCUS systems designed to be highly portable and user-friendly. Many devices feature handheld formats that connect seamlessly with smartphones and tablets, while incorporating wireless connectivity, AI-assisted interpretation, and cloud integration. These capabilities enhance image quality, improve diagnostic accuracy, and streamline workflow efficiency in clinical settings.
• For instance, Canon Medical Systems’ Viamo c100 is a compact and fully mobile ultrasound system developed for point-of-care applications. It includes an intelligent display that automatically adjusts brightness based on ambient lighting conditions, ensuring optimal image visibility and supporting accurate diagnostics across diverse healthcare environments.
• The therapeutic devices segment accounted for USD 1.6 billion in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the increasing use of ultrasound guidance in minimally invasive procedures, including needle guidance, fluid drainage, vascular access, and targeted drug delivery, which enhances procedural accuracy, reduces complications, and supports improved patient outcomes across various clinical settings.

Based on portability, the point of care ultrasound (POCUS) market is segmented into trolley-based devices and handheld devices. The trolley-based devices segment was valued at USD 2.7 billion in 2025.

• Trolley-based POCUS systems are an essential part of diagnostic imaging infrastructure in hospitals and large healthcare facilities. These systems are designed to provide high-performance imaging for point-of-care applications while offering mobility within clinical environments.
• For instance, GE Venue Go is a compact, trolley-mounted ultrasound system offering advanced imaging, AI-driven tools, and a large touchscreen interface. Its mobility and high performance make it ideal for point-of-care use in emergency rooms, ICUs, and operating theaters.
• In addition, trolley-based POCUS devices provide comprehensive imaging with mobility, supporting cardiac, abdominal, obstetric, and vascular assessments. Their robust design and larger screens deliver superior visualization, making them ideal for complex diagnostics and guided interventions.
• The handheld devices segment accounted for a 36.6% share in 2025 and is projected to grow at a robust CAGR over the forecast period. Growth is primarily driven by the increasing demand for portable and easy-to-use ultrasound solutions, enabling rapid bedside diagnostics and real-time imaging in diverse settings such as emergency care, ambulances, and remote locations, thereby improving accessibility, clinical efficiency, and patient outcomes.

Based on application, the market is segmented into emergency medicine, cardiology, obstetrics and gynecology, urology, vascular surgery, musculoskeletal, and other applications. The obstetrics and gynecology segment was valued at USD 938.4 million in 2025.

• POCUS has become an essential tool in obstetrics and gynecology, providing real-time imaging at the bedside to support rapid clinical decision-making. Unlike traditional ultrasound performed in radiology departments, POCUS enables immediate assessment during routine prenatal visits, emergency situations, and labor management.
• In obstetrics, POCUS is widely used for early pregnancy assessment, including confirmation of intrauterine pregnancy, evaluation of fetal viability, and detection of ectopic pregnancies. During later stages, it assists in monitoring fetal growth, amniotic fluid volume, placental position, and fetal presentation, which are crucial for planning delivery.
• For example, Philips Lumify is a portable, smartphone-based ultrasound solution that delivers high-quality imaging with exceptional mobility. Designed for point-of-care use, it is particularly suited for prenatal assessments and emergency obstetric care.
• The emergency medicine segment accounted for USD 752 million in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the increasing reliance on rapid bedside imaging for trauma assessment, cardiac evaluation, and critical care diagnostics, enabling faster clinical decision-making and improving patient outcomes in emergency settings.
• The cardiology segment accounted for USD 798 million in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the rising use of point-of-care ultrasound for cardiac function assessment, detection of structural abnormalities, and hemodynamic monitoring, supporting timely diagnosis and management of cardiovascular conditions.
• The urology segment accounted for USD 476 million in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the increasing application of POCUS in kidney and bladder imaging, guiding minimally invasive procedures, and improving the diagnosis of urological disorders with enhanced accuracy and efficiency.
• The vascular surgery segment accounted for USD 458.7 million in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the growing adoption of ultrasound for vascular access guidance, detection of thrombus and arterial blockages, and intraoperative imaging, which enhances procedural precision and reduces complication rates.

Based on end use, the point of care ultrasound market is segmented into hospitals, clinics, maternity centers, ambulatory surgical centers, and other end users. The hospitals segment held a significant market share of 30.6% in 2025.

• Hospitals dominate the point-of-care ultrasound (POCUS) market due to their extensive need for rapid, bedside imaging across multiple departments, including emergency rooms, ICUs, operating theaters, and general wards.
• POCUS devices are essential for real-time diagnostic assessments, guiding interventions, and improving patient outcomes in critical care, trauma, and surgical settings. Their ability to provide instant visualization of organs and tissues makes them indispensable for life-saving decisions.
• Furthermore, rising surgical volumes, increasing ICU admissions, and the growing prevalence of chronic conditions such as cardiovascular and respiratory diseases are driving demand for advanced POCUS systems. Modern hospitals are also shifting from traditional imaging workflows to portable, digitally integrated solutions equipped with wireless connectivity, AI-assisted interpretation, and seamless EHR integration for real-time data sharing and collaborative care.
• The clinics segment accounted for USD 820.6 billion in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the increasing adoption of point-of-care ultrasound for routine diagnostics, early disease detection, and real-time monitoring in outpatient settings, improving clinical efficiency and patient turnaround times.
• The maternity centers segment accounted for USD 777.6 million in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the growing use of ultrasound in prenatal screening, fetal monitoring, and obstetric care, enabling safer pregnancies and improved maternal and neonatal outcomes.
• The ambulatory surgical centers segment accounted for USD 1 billion in 2025 and is projected to grow at a steady CAGR over the forecast period. Growth is primarily driven by the rising use of ultrasound guidance in minimally invasive surgical procedures, including regional anesthesia, needle placement, and perioperative monitoring, enhancing procedural precision and reducing complications in outpatient surgical settings.

North America Point of Care Ultrasound (POCUS) Market

The North America region accounted for 42.5% of the market in 2025. The market in North America is experiencing robust expansion, driven by the region’s advanced healthcare infrastructure and technological advancements.

• The U.S. market was valued at USD 1.4 billion and USD 1.5 billion in 2022 and 2023, respectively. In 2025 the market size increased to USD 1.7 billion from USD 1.6 billion in 2024.
• The growth is primarily attributed to the increasing prevalence of chronic diseases, which drives the need for rapid and accurate diagnostic imaging.
• According to the CDC, the rising incidence of conditions such as cancer highlights the importance of timely diagnostics. POCUS enables real-time visualization of organs and tissues, supporting early detection and monitoring of critical conditions at the bedside. Its portability and efficiency make it ideal for managing large patient volumes in emergencies and critical care settings.
• The U.S. leads in both the usage and development of POCUS technologies due to its advanced healthcare infrastructure, high diagnostic testing volumes, and continuous investment in imaging innovation. Hospitals and diagnostic centers collaborate with leading manufacturers to integrate AI-powered interpretation, wireless connectivity, and cloud-based data sharing, ensuring better patient care and operational efficiency.

Europe Point of Care Ultrasound (POCUS) Market

Europe market accounted for USD 1.1 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe represents a significant and steadily growing market for POCUS, supported by advanced healthcare infrastructure and increasing demand for portable, high-quality diagnostic imaging solutions across emergency, critical care, and surgical settings. The rising preference for rapid bedside diagnostics is accelerating the adoption of POCUS technologies across hospitals and outpatient facilities.
• Many European countries benefit from well-established healthcare systems and ongoing investments in hospital modernization, ensuring broad access to advanced diagnostic tools.
• Germany remains a key contributor to regional growth, driven by its advanced healthcare system and increasing adoption of point-of-care imaging. The country’s aging population is a major growth driver; according to Statista, in 2024, approximately 22.3 million individuals were aged 40–59, while nearly 19 million were aged 65 and older. This demographic trend is increasing the prevalence of chronic and acute diseases, thereby fueling demand for rapid, bedside diagnostic solutions such as POCUS.

Asia Pacific Point of Care Ultrasound (POCUS) Market

The Asia Pacific region is projected to show a lucrative growth of about 8.4% during the forecast period.

• The Asia Pacific region represents a rapidly growing market for POCUS, driven by the increasing prevalence of chronic diseases, rising focus on early diagnosis, and continuous advancements in portable ultrasound technologies. The growing need for real-time, cost-effective diagnostic solutions is accelerating the adoption of POCUS devices across various healthcare settings.
• Countries such as China, India, and Japan are witnessing significant adoption of POCUS systems due to improving healthcare access and increasing demand for fast and accurate diagnostic capabilities. The expansion of healthcare infrastructure, including hospitals, emergency care units, and diagnostic centers, is further supporting market growth across the region.
• Additionally, supportive government initiatives aimed at strengthening point-of-care diagnostics and improving rural healthcare access are playing a key role in driving the deployment of portable ultrasound systems, enhancing diagnostic reach and clinical efficiency.
• China remains a major contributor to regional growth, supported by its rapidly aging population and increasing burden of chronic diseases. According to WHO estimates (2019), a significant proportion of the elderly population in China is affected by noncommunicable diseases (NCDs), with approximately 75% of individuals aged 60 years and above suffering from conditions such as cardiovascular diseases, diabetes, and hypertension.
• Additionally, the elderly population continues to expand rapidly, with hundreds of millions of individuals aged 60 and above. This high prevalence of chronic conditions among the aging population is increasing the demand for frequent monitoring, early diagnosis, and point-of-care diagnostics.
• Consequently, the growing disease burden is driving the adoption of advanced diagnostic solutions such as point-of-care ultrasound (POCUS), which enables rapid, real-time assessment and supports improved clinical decision-making, thereby contributing to market growth.

Latin America Point of Care Ultrasound (POCUS) Market

Brazil is experiencing significant growth in the market

• The growth of the POCUS market in Brazil is strongly driven by technological advancements and the introduction of innovative portable ultrasound devices, along with the rising prevalence of chronic diseases in the country.
• Healthcare facilities and emergency care settings in Brazil are increasingly adopting POCUS systems that provide faster, more accurate, and real-time imaging compared to traditional diagnostic methods.
• Further, technological innovations are accelerating the growth of Brazil’s POCUS market by enhancing diagnostic speed, accuracy, and efficiency. With the increasing integration of AI-powered imaging and cloud-enabled platforms, Brazil is strengthening its point-of-care diagnostic capabilities and supporting personalized medicine, ensuring sustained market expansion.

Middle East and Africa Point of Care Ultrasound (POCUS) Market

• Saudi Arabia is steadily increasing its research and development expenditure, particularly in healthcare. The government and private sector are investing heavily in modernizing healthcare infrastructure and fostering innovation in diagnostic imaging and point-of-care technologies.
• These initiatives create a strong foundation for adopting advanced solutions such as POCUS, which provides real-time imaging for rapid diagnosis and improved patient management in clinical and emergency settings.
• Further, high research and development spending accelerates advancements in personalized medicine, oncology, and critical care, all of which benefit from portable ultrasound systems that enable accurate bedside imaging and support timely clinical decisions.

Point of Care Ultrasound (POCUS) Market Share

• The global point-of-care ultrasound (POCUS) market is characterized by moderate to high competition, driven by continuous technological advancements, increasing demand for portable diagnostic solutions, and a strong focus on improving real-time clinical decision-making across healthcare settings. Manufacturers are actively investing in the development of advanced POCUS systems with enhanced imaging quality, improved portability, AI-driven diagnostic capabilities, and seamless connectivity to support efficient bedside care.
• Key players in the market include Canon Medical Systems, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and GE Healthcare, which collectively account for approximately 55% of the global market share. These companies maintain strong global presence and focus on innovation, regulatory compliance, and strategic collaborations to strengthen their market positions. Significant investments in research and development enable the introduction of next-generation handheld and portable ultrasound devices integrated with AI-powered imaging, cloud-based data sharing, and telehealth functionalities to enhance diagnostic accuracy and workflow efficiency.
• In addition to major multinational companies, several regional and emerging players contribute to market competition by introducing cost-effective and compact ultrasound systems targeting price-sensitive markets, particularly in emerging economies.
• As demand for point-of-care diagnostics increases and healthcare infrastructure expands globally, competition in the POCUS market is expected to intensify. Manufacturers are prioritizing innovation, value-based pricing strategies, integration of telehealth and smart monitoring systems, and the development of energy-efficient and eco-friendly devices to strengthen their market positioning and improve accessibility to advanced diagnostic solutions.

Point of Care Ultrasound (POCUS) Market Companies

Few of the prominent players operating in the point of care ultrasound market include:

• Butterfly Network
• Canon Medical Systems
• Clarius Mobile Health
• Chison Medical Imaging
• Esaote SpA
• Fujifilm
• Fukuda Denshi
• BenQ Medical Technology
• GE Healthcare
• Koninklijke Philips
• Shenzhen Mindray
• Siemens Healthineers
• SAMSUNG Healthcare
• Viatom Technology
• Vave Health

• GE HealthCare

GE HealthCare is a global leader in medical imaging and diagnostic solutions, maintaining a strong presence in the POCUS segment. The company provides advanced portable ultrasound systems, including the Vscan Air and Venue series, designed for rapid bedside imaging in emergencies, critical care, and primary care settings.

• Koninklijke Philips

Philips Healthcare is a leading innovator in diagnostic imaging, offering versatile POCUS solutions such as Lumify, a smartphone-based ultrasound system that combines portability with advanced imaging capabilities.

• Fujifilm

Fujifilm Sonosite is recognized as a pioneer in handheld and portable ultrasound technology. The company’s POCUS portfolio includes rugged, lightweight systems like the Sonosite PX and M-Turbo, engineered for point-of-care applications in emergency medicine, anesthesia, and critical care.

Point of Care Ultrasound (POCUS) Industry News

• In October 2025, GE HealthCare introduced AI-enabled and digital enhancements to its Venue POCUS systems, designed to improve diagnostic confidence and workflow efficiency. This advancement strengthens GE’s market leadership by providing cutting-edge technology that reduces operator variability, accelerates clinical decision-making, and supports premium pricing strategies.
• In November 2025, FUJIFILM Sonosite announced the launch of Sonosite MT, the latest evolution in its portable ultrasound systems. This innovation reinforces the company’s leadership in the POCUS market by offering advanced portability and improved imaging capabilities, catering to emergency and critical care settings.

The point of care ultrasound market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Diagnostic devices
• Therapeutic devices

Market, By Portability

• Trolley based devices
• Handheld devices

Market, By Application

• Emergency medicine
• Cardiology
• Obstetrics and gynecology
• Urology
• Vascular surgery
• Musculoskeletal
• Other applications

Market, By End Use

• Hospitals
• Clinics
• Maternity centers
• Ambulatory surgical centers (ASCs)
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE